Skip to content

Therapeutic Angiogenesis by autologous adipose-derived regenelative Cell Transplantation

Therapeutic Angiogenesis by autologous adipose-derived regenelative Cell Transplantation - TACT-ADRCs

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010143
Enrollment
40
Registered
2013-03-01
Start date
2013-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ASO, Buerger&#39

Interventions

The process is started with the harvest of a 300 mg of adipose tissue by standard manual liposuction under local anesthesia using a syringe and cannula. ADRCs are separated by the fully automated isol

Sponsors

Nagoya University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Male and female, their age are more than 25 years old and less than 80 years old. 2.Symptoms include rest pain, with or without established ischemic ulcers. (Fontaine class III-IV) A minimum of 4 weeks of conservative therapy without evidence of significant healing. 3.Patients accepted an informed consent.

Exclusion criteria

Exclusion criteria: 1.Patient with insufficient amount of adipose tissue. 2.Patients does not accept an informed consent. 3.Any concomitant diseases with a life expectancy of <1 year. 4.Previous (within 5 years) or current history of neoplasm. Clinically significant abnormality in laboratory tests, including tumor markers. 5.Ischemic heart desease without revascularization. 6.Untreateed diabetic retinopathy. 7.Severe infection. 8.Severe Liver and/or renal dysfunction (except for patients under hemodialysis) 9.Severe hematopoietic disease 10.Pregnant 11.Patient whom physicians consider as inadequate

Design outcomes

Primary

MeasureTime frame
1. The safety of ADRCs transplantation. 2. Rescue rate of amputation.

Secondary

MeasureTime frame
1.Improvement rate of ischemic gangrene. 2.Improvement of QOL using Numerical Rating Scale (NRS) 3.ABI 4.SPP 5.Evaluation of angiogenesis by imaging 6.Walking distance in 6 minutes

Countries

Japan

Contacts

Public ContactYuuki Shimizu

Nagoya University School of Medicine Cardiology

shimi123@med.nagoya-u.ac.jp052-744-2149

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026